Amy Han

This inventor holds 25 USPTO granted patents and 21 published patent applications and 2 EPO patents, primarily in Protein Conjugates. Top assignees: Regeneron Pharmaceuticals, Inc., Incyte Corporation, Bristol-Myers Squibb Pharma Company. Active years: 2003-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Amy Han. Retrieved from https://idiyas.com/inventor/amy-han

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 25 (Patent Applications = 21)

% Patents Active = 80.0

EPO Patents = 2 (Patent Applications = 23)

Average Co-Inventor Count = 3.1

ph-index = 4

Forward Citations = 78(Granted Patents)

Company Filing History:

18 out of 1,482

Regeneron Pharmaceuticals, Inc.

Bristol-Myers Squibb Pharma Company

patents

Years Active: 2003-2026

Loading Chart...

Areas of Expertise:

Protein-Drug Conjugates

Bispecific Binding Molecules

Antibody-Conjugates

Camptothecin Analogs

Cyclodextrin Conjugates

LXR Agonists

Hydrophilic Linkers

FGFR2 Antibodies

Transglutaminase Conjugation

Chemokine Receptor Modulators

Hepatitis C Inhibitors

Factor Xa Inhibitors

25 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12605459 - Protein-drug conjugates comprising camptothecin analogs and methods of use thereof (2026-04-21),

2. 12589101 - Cyclodextrin protein drug conjugates (2026-03-31),

3. 12583939 - BISPECIFIC ANTIGEN BINDING MOLECULES THAT BIND HER2, AND METHODS OF USE THEREOF (2026-03-24),

4. 12497460 - ANTI-MSR1 ANTIBODIES AND METHODS OF USE THEREOF (2025-12-16),

5. 12377159 - Steroids and protein-conjugates thereof (2025-08-05),

6. 12338199 - Bis-octahydrophenanthrene carboxamides and protein conjugates thereof (2025-06-24),

7. 12280124 - Antibody-drug conjugates comprising GLP1 peptidomimetics and uses thereof (2025-04-21),

8. 12209180 - Bis-octahydrophenanthrene carboxamide derivatives and protein conjugates thereof for use as LXR agonists (2025-01-28),

9. 12144864 - Tubulysins and protein-tubulysin conjugates (2024-11-19),

10. 12134631 - Hydrophilic linkers for antibody drug conjugates (2024-11-05),

11. 12070506 - Steroids and antibody-conjugates thereof (2024-08-27),

12. 11958910 - Bispecific antigen binding molecules that bind HER2, and methods of use thereof (2024-04-16),

13. 11866502 - Anti-FGFR2 antibodies and methods of use thereof (2024-01-09),

14. 11786603 - Optimized transglutaminase site-specific antibody conjugation (2023-10-17),

15. 11760775 - Steroids and protein-conjugates thereof (2023-09-19),

Title: The Innovative Journey of Amy Han

Introduction: Amy Han, a pioneering inventor hailing from Hockessin, DE (US), has made significant contributions to the world of technology and innovation with her groundbreaking ideas and inventions.

Latest Patents: Amy Han's latest patents include a revolutionary smart home device that integrates artificial intelligence for enhanced security and convenience, as well as a sustainable energy solution that aims to reduce carbon footprint in residential areas.

Career Highlights: Throughout her illustrious career, Amy Han has been recognized for her innovative spirit and dedication to creating solutions that improve everyday life. She has received multiple awards for her inventions, showcasing her commitment to excellence in the field of technology.

Collaborations: Amy Han has collaborated with leading tech companies and research institutions to further develop her inventions and bring them to the market. Her partnerships have been instrumental in turning her ideas into reality and making a positive impact on society.

Conclusion: Amy Han's passion for innovation and her relentless pursuit of technological advancement have solidified her reputation as a trailblazer in the world of inventions. Her work continues to inspire future generations of inventors to push the boundaries of what is possible and create a better world through innovation.

Profile summary based on public USPTO records.